Research resource: Identification of novel coregulators specific for thyroid hormone receptor-β2

Molecular Endocrinology

Volumn 27, Issue 5, 2013, Pages 840-859

  Hahm, Johnnie B ^a   Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; MEMBRANE PROTEIN; STREPTAVIDIN; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA 1; THYROID HORMONE RECEPTOR BETA 2; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CELL LYSATE; CELLULAR DISTRIBUTION; COCHLEA; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GENE CONTROL; GENE LOCUS; GENETIC ANALYSIS; HEART OUTPUT; HUMAN; HUMAN CELL; HYPOPHYSIS; HYPOTHALAMUS; ISOTOPE LABELING; LIGAND BINDING; LIPID LIVER LEVEL; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MAMMAL CELL; NEGATIVE FEEDBACK; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; RETINA; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL EXTRACTS; CELL LINE; CHROMATOGRAPHY, LIQUID; DNA; GENES, REPORTER; HUMANS; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; THYROID HORMONE RECEPTORS BETA; TRANSCRIPTIONAL ACTIVATION;

EID: 84876843820     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1117     Document Type: Article

References (118)

1. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81:1097-1142.
2. Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol. 2000;62:439-466.
3. Flamant F, Baxter JD, Forrest D, et al. International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev. 2006;58:705-711.
4. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139-170.
5. Bassett JH, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol. 2003;213:1-11.
6. Privalsky ML. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol. 2004;66: 315-360.
7. Wolf IM, Heitzer MD, Grubisha M, DeFranco DB. Coactivators and nuclear receptor transactivation. J Cell Biochem. 2008;104: 1580-1586.
8. Bulynko YA, O'Malley BW. Nuclear Receptor Coactivators: Structural and Functional Biochemistry. Biochemistry. 2010
9. Westin S, Rosenfeld MG, Glass CK. Nuclear receptor coactivators. Adv Pharmacol. 2000;47:89-112.
10. Watson PJ, Fairall L, Schwabe JW. Nuclear hormone receptor co-repressors: Structure and function. Mol Cell Endocrinol. 2011
11. Lazar MA. Nuclear receptor corepressors. Nucl Recept Signal. 2003;1:e001.
12. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000;14:121-141.
13. Lin BC, Hong SH, Krig S, Yoh SM, Privalsky ML. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol. 1997;17: 6131-6138.
14. Ribeiro RC, Apriletti JW, Wagner RL, et al. Mechanisms of thyroid hormone action: insights from x-ray crystallographic and functional studies. Recent Prog Horm Res. 1998;53:351-392; discussion 392-394.
15. Cheng SY. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord. 2000;1:9-18.
16. Murata Y. Multiple isoforms of thyroid hormone receptor: an analysis of their relative contribution in mediating thyroid hormone action. Nagoya J Med Sci. 1998;61:103-115.
17. Abel ED, Boers ME, Pazos-Moura C, et al. Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest. 1999;104:291-300.
18. Cheng SY. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Steroids. 2005;70: 450-454.
19. Wondisford FE. Thyroid hormone action: insight from transgenic mouse models. J Investig Med. 2003;51:215-220.
20. Langlois MF, Zanger K, Monden T, Safer JD, Hollenberg AN, Wondisford FE. A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation. J Biol Chem. 1997;272:24927-24933.
21. Safer JD, Langlois MF, Cohen R, et al. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Mol Endocrinol. 1997; 11:16-26.
22. Yang Z, Hong SH, Privalsky ML. Transcriptional anti-repression. Thyroid hormone receptor β-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex. J Biol Chem. 1999;274:37131-37138.
23. Yang Z, Privalsky ML. Isoform-specific transcriptional regulation by thyroid hormone receptors: hormone-independent activation operates through a steroid receptor mode of co-activator interaction. Mol Endocrinol. 2001;15:1170-1185.
24. 3 receptor mutants that selectively impair β2 isoform function. Mol Endocrinol. 2005;19: 1529-1542.
25. Privalsky ML, Lee S, Hahm JB, Young BM, Fong RN, Chan IH. The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors. J Biol Chem. 2009;284:19554-19563.
26. Lee S, Young BM, Wan W, Chan IH, Privalsky ML. A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)β2. Mol Endocrinol. 2011;25:1111-1125.
27. Oberste-Berghaus C, Zanger K, Hashimoto K, Cohen RN, Hollenberg AN, Wondisford FE. Thyroid hormone-independent interaction between the thyroid hormone receptor beta2 amino terminus and coactivators. J Biol Chem. 2000;275:1787-1792.
28. Tian H, Mahajan MA, Wong CT, Habeos I, Samuels HH. The N-terminal A/B domain of the thyroid hormone receptor-β2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain. Mol Endocrinol. 2006;20:2036-2051.
29. Sjöberg M, Vennström B. Ligand-dependent and-independent transactivation by thyroid hormone receptor beta 2 is determined by the structure of the hormone response element. Mol Cell Biol. 1995;15:4718-4726.
30. Lee S, Privalsky ML. Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Mol Endocrinol. 2005;19:863-878.
31. Mengeling BJ, Pan F, Privalsky ML. Novel mode of deoxyribonucleic acid recognition by thyroid hormone receptors: thyroid hormone receptor β-isoforms can bind as trimers to natural response elements comprised of reiterated half-sites. Mol Endocrinol. 2005; 19:35-51.
32. Chan IH, Privalsky ML. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene. 2006; 25:3576-3588.
33. Wong CW, Privalsky ML. Transcriptional silencing is defined by isoform-and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol. 1998;18: 5724-5733.
34. Goodson ML, Farboud B, Privalsky ML. High throughput analysis of nuclear receptor-cofactor interactions. Methods Mol Biol. 2009;505:157-169.
35. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006;1:2856-2860.
36. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002;74:5383-5392.
37. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75:4646-4658.
38. Malovannaya A, Lanz RB, Jung SY, et al. Analysis of the human endogenous coregulator complexome. Cell. 2011;145:787-799.
39. Nguyen TT, Ma LN, Slovak ML, Bangs CD, Cherry AM, Arber DA. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer. 2006;45:918-932.
40. Ball JR, Ullman KS. Versatility at the nuclear pore complex: lessons learned from the nucleoporin Nup153. Chromosoma. 2005; 114:319-330.
41. Ullman KS, Shah S, Powers MA, Forbes DJ. The nucleoporin nup153 plays a critical role in multiple types of nuclear export. Mol Biol Cell. 1999;10:649-664.
42. Shah S, Forbes DJ. Separate nuclear import pathways converge on the nucleoporin Nup153 and can be dissected with dominantnegative inhibitors. Curr Biol. 1998;8:1376-1386.
43. Walther TC, Fornerod M, Pickersgill H, Goldberg M, Allen TD, Mattaj IW. The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins. EMBO J. 2001;20:5703-5714.
44. Van de Vosse DW, Wan Y, Wozniak RW, Aitchison JD. Role of the nuclear envelope in genome organization and gene expression. Wiley Interdiscip Rev Syst Biol Med. 2011;3:147-166.
45. Brown CR, Silver PA. Transcriptional regulation at the nuclear pore complex. Curr Opin Genet Dev. 2007;17:100-106.
46. Enarson P, Enarson M, Bastos R, Burke B. Amino-terminal sequences that direct nucleoporin nup153 to the inner surface of the nuclear envelope. Chromosoma. 1998;107:228-236.
47. Sukegawa J, Blobel G. A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. Cell. 1993;72:29-38.
48. Mendjan S, Taipale M, Kind J, et al. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol Cell. 2006;21:811-823.
49. Vaquerizas JM, Suyama R, Kind J, Miura K, Luscombe NM, Akhtar A. Nuclear pore proteins nup153 and megator define transcriptionally active regions in the Drosophila genome. PLoS Genet. 2010;6:e1000846.
50. Yamashiro S, Noguchi T, Mabuchi I. Localization of two IQGAPs in cultured cells and early embryos of Xenopus laevis. Cell Motil Cytoskeleton. 2003;55:36-50.
51. Johnson M, Sharma M, Brocardo MG, Henderson BR. IQGAP1 translocates to the nucleus in early S-phase and contributes to cell cycle progression after DNA replication arrest. Int J Biochem Cell Biol. 2011;43:65-73.
52. Briggs MW, Sacks DB. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep. 2003;4:571-574.
53. Rittmeyer EN, Daniel S, Hsu SC, Osman MA. A dual role for IQGAP1 in regulating exocytosis. J Cell Sci. 2008;121:391-403.
54. Yamashiro S, Abe H, Mabuchi I. IQGAP2 is required for the cadherin-mediated cell-to-cell adhesion in Xenopus laevis embryos. Dev Biol. 2007;308:485-493.
55. Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA. IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci. 2009;122:2024-2033.
56. Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S. IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nat Cell Biol. 2008;10:971-978.
57. Briggs MW, Li Z, Sacks DB. IQGAP1-mediated stimulation of transcriptional co-activation by β-catenin is modulated by calmodulin. J Biol Chem. 2002;277:7453-7465.
58. Sharma S, Findlay GM, Bandukwala HS, et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci U S A. 2011;108:11381-11386.
59. White CD, Khurana H, Gnatenko DV, et al. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol. 2010;10:125.
60. Chen F, Zhu HH, Zhou LF, Wu SS, Wang J, Chen Z. IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation. Exp Mol Med. 2010;42:477-483.
61. Schmidt VA, Chiariello CS, Capilla E, Miller F, Bahou WF. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. Mol Cell Biol. 2008;28:1489-1502.
62. Lin KH, Shieh HY, Chen SL, Hsu HC. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog. 1999;26:53-61.
63. Cheng SY. Thyroid hormone receptor mutations in cancer. Mol Cell Endocrinol. 2003;213:23-30.
64. Tsubota A, Matsumoto K, Mogushi K, et al. IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress. Carcinogenesis. 2010;31: 504-511.
65. Robertson NG, Khetarpal U, Gutiérrez-Espeleta GA, Bieber FR, Morton CC. Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. Genomics. 1994;23:42-50.
66. Forrest D, Erway LC, Ng L, Altschuler R, Curran T. Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet. 1996;13:354-357.
67. Van Laer L, Huyghe JR, Hannula S, et al. A genome-wide association study for age-related hearing impairment in the Saami. Eur J Hum Genet. 2010;18:685-693.
68. Gao Q, Srinivasan S, Boyer SN, Wazer DE, Band V. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol Cell Biol. 1999;19:733-744.
69. Singh L, Gao Q, Kumar A, et al. The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins. J Virol. 2003;77:1614-1620.
70. Chih DY, Park DJ, Gross M, Idos G, Vuong PT, Hirama T, Chumakov AM, Said J, Koeffler HP. Protein partners of C/EBP∈. Exp Hematol. 2004;32:1173-1181.
71. Tsai IC, Amack JD, Gao ZH, Band V, Yost HJ, Virshup DM. A Wnt-CKIvarβ-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein. Dev Cell. 2007; 12:335-347.
72. Gao Q, Kumar A, Singh L, et al. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res. 2002;62:3315-3321.
73. Unoki M, Nishidate T, Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene. 2004;23:7601-7610.
74. Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H. The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res. 2010;38:1796-1804.
75. Kim JK, Estève PO, Jacobsen SE, Pradhan S. UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res. 2009;37:493-505.
76. Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M. Recognition of hemi-methylatedDNAby the SRA protein UHRF1 by a base-flipping mechanism. Nature. 2008;455:818-821.
77. Sharif J, Muto M, Takebayashi S, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature. 2007;450:908-912.
78. Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science. 2007;317:1760-1764.
79. Jenkins Y, Markovtsov V, Lang W, et al. Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell. 2005;16:5621-5629.
80. Karagianni P, Amazit L, Qin J, Wong J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol. 2008;28:705-717.
81. Qin W, Leonhardt H, Spada F. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J Cell Biochem. 2011;112:439-444.
82. Zhang Y, Yang W, Mok CC, et al. Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun. 2011;12: 231-234.
83. Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009;41: 1228-1233.
84. Oedegaard KJ, Greenwood TA, Johansson S, et al. Agenome-wide association study of bipolar disorder and comorbid migraine. Genes Brain Behav. 2010;9:673-680.
85. Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet. 2010;19:4072-4082.
86. Semova N, Kapanadze B, Corcoran M, Kutsenko A, Baranova A, Semov A. Molecular cloning, structural analysis, and expression of a human IRLB, MYC promoter-binding protein: new DENN domain-containing protein family emerges small star, filled. Genomics. 2003;82:343-354.
87. Stasiv YZ, Mashkova TD, Chernov BK, Sokolova IV, Itkes AV, Kisselev LL. Cloning of a cDNA encoding a human protein which binds a sequence in the c-myc gene similar to the interferon-stimulated response element. Gene. 1994;145:267-272.
88. Bartholomeeusen K, Christ F, Hendrix J, et al. Lens epitheliumderived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ. J Biol Chem. 2009;284:11467-11477.
89. Gunther M, Laithier M, Brison O. A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. Mol Cell Biochem. 2000;210:131-142.
90. Nozawa RS, Nagao K, Masuda HT, et al. Human POGZ modulates dissociation of HP1α from mitotic chromosome arms through Aurora B activation. Nat Cell Biol. 2010;12:719-727.
91. Kang BG, Shin JH, Yi JK, et al. Corepressor MMTR/DMAP1 is involved in both histone deacetylase 1-and TFIIH-mediated transcriptional repression. Mol Cell Biol. 2007;27:3578-3588.
92. Lee GE, Kim JH, Taylor M, Muller MT. DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair. J Biol Chem. 2010;285:37630-37640.
93. Rountree MR, Bachman KE, Baylin SB. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet. 2000;25:269-277.
94. Doyon Y, Selleck W, Lane WS, Tan S, Côté J. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol. 2004;24:1884-1896.
95. Cai Y, Jin J, Tomomori-Sato C, et al. Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex. J Biol Chem. 2003;278: 42733-42736.
96. Moorefield KS, Yin H, Nichols TD, Cathcart C, Simmons SO, Horowitz JM. Sp2 localizes to subnuclear foci associated with the nuclear matrix. Mol Biol Cell. 2006;17:1711-1722.
97. Terrados G, Finkernagel F, Stielow B, et al. Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. Nucleic Acids Res. 2012;40:7844-7857.
98. Phan D, Cheng CJ, Galfione M, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004;64: 3072-3078.
99. Das A, Fernandez-Zapico ME, Cao S, et al. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem. 2006; 281:39105-39113.
100. Herrmann H, Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu Rev Biochem. 2004;73:749-789.
101. Carmo-Fonseca M, David-Ferreira JF. Interactions of intermediate filaments with cell structures. Electron Microsc Rev. 1990;3: 115-141.
102. Lian N, Wang W, Li L, Elefteriou F, Yang X. Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J Biol Chem. 2009;284:30518-30525.
103. Mergui X, Puiffe ML, Valteau-Couanet D, Lipinski M, Benard J, Amor-Gueret M. p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma. BMC Cancer. 2010;10:473.
104. Fujimoto H, Woo GH, Inoue K, et al. Increased cellular distribution of vimentin and Ret in the cingulum induced by developmental hypothyroidism in rat offspring maternally exposed to antithyroid agents. Reprod Toxicol. 2012;34:93-100.
105. Evans IM, Pickard MR, Sinha AK, Leonard AJ, Sampson DC, Ekins RP. Influence of maternal hyperthyroidism in the rat on the expression of neuronal and astrocytic cytoskeletal proteins in fetal brain. J Endocrinol. 2002;175:597-604.
106. Zamoner A, Barreto KP, Filho DW, et al. Propylthiouracil-induced congenital hypothyroidism upregulates vimentin phosphorylation and depletes antioxidant defenses in immature rat testis. J Mol Endocrinol. 2008;40:125-135.
107. Borg JP, Marchetto S, Le Bivic A, et al. ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol. 2000;2:407-414.
108. Izawa I, Nishizawa M, Hayashi Y, Inagaki M. Palmitoylation of ERBIN is required for its plasma membrane localization. Genes to Cells. 2008;13:691-701.
109. Huang YZ, Zang M, Xiong WC, Luo Z, Mei L. Erbin suppresses the MAP kinase pathway. J Biol Chem. 2003;278:1108-1114.
110. Dai P, Xiong WC, Mei L. Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex. J Biol Chem. 2006;281:927-933.
111. Dai F, Chang C, Lin X, Dai P, Mei L, Feng XH. Erbin inhibits transforming growth factor β signaling through a novel Smadinteracting domain. Mol Cell Biol. 2007;27:6183-6194.
112. Ress A, Moelling K. The PDZ protein erbin modulates β-catenindependent transcription. Eur Surg Res. 2008;41:284-289.
113. Favre B, Fontao L, Koster J, et al. The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin β4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. J Biol Chem. 2001;276:32427-32436.
114. Qian Z, Wilusz J. GRSF-1: a poly(A)+ mRNA binding protein which interacts with a conserved G-rich element. Nucleic Acids Res. 1994;22:2334-2343.
115. Kash JC, Cunningham DM, Smit MW, et al. Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis. J Virol. 2002;76:10417-10426.
116. Park YW, Wilusz J, Katze MG. Regulation of eukaryotic protein synthesis: selective influenza viral mRNA translation is mediated by the cellular RNA-binding protein GRSF-1. Proc Natl Acad Sci U S A. 1999;96:6694-6699.
117. Ufer C, Wang CC, Fähling M, et al. Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes Dev. 2008;22:1838-1850.
118. Lickert H, Cox B, Wehrle C, Taketo MM, Kemler R, Rossant J. Dissecting Wnt/β-catenin signaling during gastrulation using RNA interference in mouse embryos. Development. 2005;132: 2599-2609.